Schwartz Sheree R, Clouse Kate, Yende Nompumelelo, Van Rie Annelies, Bassett Jean, Ratshefola Mamothe, Pettifor Audrey
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Drive 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC, 27599, USA,
Matern Child Health J. 2015 Sep;19(9):2029-37. doi: 10.1007/s10995-015-1715-0.
The objective of this study was to assess the acceptability and feasibility of a cell phone based case manager intervention targeting HIV-infected pregnant women on highly-active antiretroviral therapy (HAART). Pregnant women ≥36 weeks gestation attending antenatal care and receiving HAART through the Option B+ program at a primary care clinic in South Africa were enrolled into a prospective pilot intervention to receive text messages and telephone calls from a case manager through 6 weeks postpartum. Acceptability and feasibility of the intervention were assessed along with infant HIV testing rates and 10-week and 12-month postpartum maternal retention in care. Retention outcomes were compared to women of similar eligibility receiving care prior to the intervention. Fifty women were enrolled into the pilot from May to July 2013. Most (70%) were HAART-naive at time of conception and started HAART during antenatal care. During the intervention, the case manager sent 482 text messages and completed 202 telephone calls, for a median of 10 text messages and 4 calls/woman. Ninety-six percent completed the postpartum interview and 47/48 (98%) endorsed the utility of the intervention. Engagement in 10-week postpartum maternal HIV care was >90% in the pre-intervention (n = 50) and intervention (n = 50) periods; by 12-months retention fell to 72% and was the same across periods. More infants received HIV-testing by 10-weeks in the intervention period as compared to pre-intervention (90.0 vs. 63.3%, p < 0.01). Maternal support through a cell phone based case manager approach was highly acceptable among South African HIV infected women on HAART and feasible, warranting further assessment of effectiveness.
本研究的目的是评估针对接受高效抗逆转录病毒疗法(HAART)的感染艾滋病毒的孕妇的基于手机的病例管理干预措施的可接受性和可行性。在南非一家初级保健诊所接受产前护理并通过B+方案接受HAART的妊娠≥36周的孕妇被纳入一项前瞻性试点干预措施,在产后6周内接收来自病例管理人员的短信和电话。评估了干预措施的可接受性和可行性,以及婴儿艾滋病毒检测率和产后10周及12个月产妇的护理保留率。将保留结果与干预前接受护理的具有相似资格的妇女进行比较。2013年5月至7月,50名妇女被纳入该试点。大多数(70%)在受孕时未接受过HAART,并在产前护理期间开始接受HAART。在干预期间,病例管理人员发送了482条短信,完成了202次电话呼叫,每位妇女平均收到10条短信和4次电话。96%的人完成了产后访谈,47/48(98%)认可了干预措施的效用。干预前(n = 50)和干预期间(n = 50),产后10周产妇艾滋病毒护理的参与率>90%;到12个月时,保留率降至72%,各时期相同。与干预前相比,干预期间更多婴儿在10周时接受了艾滋病毒检测(90.0%对63.3%,p < 0.01)。通过基于手机的病例管理方法提供的产妇支持在接受HAART的南非感染艾滋病毒妇女中非常可接受且可行,值得进一步评估其有效性。